• Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharmaceuticals

Aurobindo Pharma Ltd

+ Add to Watchlist


547.80 INR 10.40 1.86%

As of 07:05:38 ET on 04/16/2014.

Snapshot for Aurobindo Pharma Ltd (ARBP)

Open: 560.00 Day's Range: 545.80 - 562.45 Volume: 1,812,049
Previous Close: 558.20 52wk Range: 138.35 - 575.95 1-Yr Rtn: +205.61%

Stock Chart for ARBP

No chart data available.
  • ARBP:IN 547.80
  • 1D
  • 1M
  • 1Y
Interactive ARBP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ARBP

Current P/E Ratio (ttm) 54.2732
Estimated P/E(03/2014) 13.7321
Relative P/E vs. SENSEX 3.1097
Earnings Per Share (INR) (ttm) 10.0934
Est. EPS (INR) (03/2014) 39.8920
Est. PEG Ratio 0.3516
Market Cap (M INR) 159,660.16
Shares Outstanding (M) 291.46
30 Day Average Volume 3,227,993
Price/Book (mrq) 6.1220
Price/Sale (ttm) 2.7238
Dividend Indicated Gross Yield 0.23%
Cash Dividend (INR) 1.2500
Dividend Ex-Date 11/19/2013
5 Year Dividend Growth 7.84%
Next Earnings Announcement 05/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ARBP

No data available

Company Profile & Key Executives for ARBP

Aurobindo Pharma Limited manufactures and markets oral and sterile antibiotics, antibacterials, anti-ulcerants and other generic basic drugs. Products include semi-synthetic penicillin drugs like ampicillin and amoxycillinas well as antibiotics, which include cloxacillin and dicloxacillin. The Company also manufactures formulations like astemizole, domeperidone and omeprazole.

K Nithyananda ReddyVice ChairmanN GovindarajanManaging Director
M Madan Mohan ReddyExecutive DirectorM SivakumaranExecutive Director
More Company Profile & Key Executives for ARBP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil